Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On the Influence of Fabrication Methods and Materials for mRNA-LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo.
Bi D, Wilhelmy C, Unthan D, Keil IS, Zhao B, Kolb B, Koning RI, Graewert MA, Wouters B, Zwier R, Bussmann J, Hankemeier T, Diken M, Haas H, Langguth P, Barz M, Zhang H. Bi D, et al. Among authors: langguth p. Adv Healthc Mater. 2024 Oct;13(26):e2401252. doi: 10.1002/adhm.202401252. Epub 2024 Jun 25. Adv Healthc Mater. 2024. PMID: 38889433
Quantitative size-resolved characterization of mRNA nanoparticles by in-line coupling of asymmetrical-flow field-flow fractionation with small angle X-ray scattering.
Graewert MA, Wilhelmy C, Bacic T, Schumacher J, Blanchet C, Meier F, Drexel R, Welz R, Kolb B, Bartels K, Nawroth T, Klein T, Svergun D, Langguth P, Haas H. Graewert MA, et al. Among authors: langguth p. Sci Rep. 2023 Sep 22;13(1):15764. doi: 10.1038/s41598-023-42274-z. Sci Rep. 2023. PMID: 37737457 Free PMC article.
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy.
Bartneck J, Hartmann AK, Stein L, Arnold-Schild D, Klein M, Stassen M, Marini F, Pielenhofer J, Meiser SL, Langguth P, Mack M, Muth S, Probst HC, Schild H, Radsak MP. Bartneck J, et al. Among authors: langguth p. Front Immunol. 2023 Oct 2;14:1267866. doi: 10.3389/fimmu.2023.1267866. eCollection 2023. Front Immunol. 2023. PMID: 37849753 Free PMC article.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Hartmann AK, Bartneck J, Pielenhofer J, Meiser SL, Arnold-Schild D, Klein M, Stassen M, Schild H, Muth S, Probst HC, Langguth P, Grabbe S, Radsak MP. Hartmann AK, et al. Among authors: langguth p. Front Immunol. 2023 Sep 1;14:1238861. doi: 10.3389/fimmu.2023.1238861. eCollection 2023. Front Immunol. 2023. PMID: 37727790 Free PMC article.
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
Sohl J, Hartmann AK, Hahlbrock J, Bartneck J, Stassen M, Klein M, Bros M, Grabbe S, Marini F, Woods K, Guezguez B, Mack M, Schild H, Muth S, Melchior F, Probst HC, Langguth P, Radsak MP. Sohl J, et al. Among authors: langguth p. NPJ Vaccines. 2023 Jun 22;8(1):94. doi: 10.1038/s41541-023-00689-9. NPJ Vaccines. 2023. PMID: 37349361 Free PMC article. No abstract available.
298 results